Alpa LaboratoriesNSE:ALPA -0.35%75 Net Margin % is 4.40% as of Mar. 2026, which is 57% below its 10-year median of 10.14. GuruFocus rates NSE:ALPA with a GF Score™ of 75/100 and a GF Value™ of ₹92.74 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, Alpa Laboratories ranks better than 76.99% on this metric.
The historical rank and industry rank for Alpa Laboratories's Net Margin % or its related term are showing as below:
NSE:ALPA'
s Net Margin % Range Over the Past 10 Years
Min: 1.32 Med: 10.14 Max: 17.34
Current: 14.33
NSE:ALPA's Net Margin % is ranked better than 76.99% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs NSE:ALPA: 14.33
Alpa Laboratories (NSE:ALPA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Alpa Laboratories Net Margin % Related Terms
Alpa Laboratories Net Margin % Historical Data
* Premium members only.
The historical data trend for Alpa Laboratories's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpa Laboratories Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Net Margin % distribution charts can be found below:
* The bar in red indicates where Alpa Laboratories's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpa Laboratories (NSE:ALPA) has a Net Margin % of 4.40% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Alpa Laboratories and its competitors. This is 57% below median its historical median of 10.14. Over the past decade, Alpa Laboratories' Net Margin % has ranged from 1.32 to 17.34. According to the industry distribution chart, Alpa Laboratories ranks #220 out of 956 companies in the Drug Manufacturers industry, placing it in the top 23%.
Is Alpa Laboratories' Net Margin % too high?
Alpa Laboratories' current Net Margin % of 4.40% is 57% below median its 10-year median of 10.14. Over the past 10 years, this metric has ranged from a low of 1.32 to a high of 17.34. The Drug Manufacturers industry median Net Margin % is 5.56. Alpa Laboratories' value of 4.40% is 20.9% below this industry median. Based on the distribution chart, Alpa Laboratories ranks #220 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Alpa Laboratories has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alpa Laboratories' Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Alpa Laboratories ranks #220 out of 956 companies for Net Margin %. This places Alpa Laboratories in the top 23% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.56. Alpa Laboratories' value of 4.40% is 20.9% below this benchmark. Historically, Alpa Laboratories' own Net Margin % has ranged from 1.32 to 17.34 over the past decade. While the company's 10-year median is 10.14 vs. the industry median of 5.56, Alpa Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpa Laboratories's current Net Margin % of 4.40% is 20.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Alpa Laboratories and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpa Laboratories's current Net Margin % is 4.40%, which is 57% below median its own 10-year median of 10.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alpa Laboratories (NSE:ALPA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹92.74, compared to a current price of ₹68.50 — trading 26.1% below its estimated fair value. The current Net Margin % is 4.40%, which is 57% below median its 10-year median of 10.14 and 20.9% below the Drug Manufacturers industry median of 5.56. Alpa Laboratories' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Alpa Laboratories (NSE:ALPA), the current Net Margin % is 4.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?
Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued.
The current stock price of ₹68.50 is trading 26.1% below its estimated GF Value™ of ₹92.74.
GuruFocus considers Alpa Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:ALPA:
Net Margin %: 4.40% (57% below median its 10-year median of 10.14)
GF Value™: ₹92.74 vs. price of ₹68.50 (26.1% below fair value)
Industry Position: 20.9% below the Drug Manufacturers median (#220 of 956)
No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
75GF Score
Get the complete analysis for NSE:ALPA
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ALPA has been successfully added to your 
